Du benytter en nettleser vi ikke støtter. Se informasjon om nettlesere

13. Referanser

Adam, R., Chiche, L., Aloia, T., Elias, D., Salmon, R., Rivoire, M., . . . Mentha, G. (2006). Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Annals of surgery, 244(4), 524-535. https://doi.org/10.1097/01.sla.0000239036.46827.5f

Aldrich, J. D., Raghav, K. P. S., Varadhachary, G. R., Wolff, R. A., & Overman, M. J. (2019). Retrospective Analysis of Taxane-Based Therapy in Small Bowel Adenocarcinoma. Oncologist, 24(6), e384-e386. https://doi.org/10.1634/theoncologist.2018-0573

Algaba, A., Guerra, I., Marín-Jiménez, I., Quintanilla, E., López-Serrano, P., García-Sánchez, M. C., . . . Bermejo, F. (2015). Incidence, management, and course of cancer in patients with inflammatory bowel disease. Journal of Crohn's & colitis, 9(4), 326-333. https://doi.org/10.1093/ecco-jcc/jjv032

Amin, M. B., Edge, S. B., Greene, F. L., Byrd, D. R., Brookland, R., K., Washington, M. K., . . . Meyer, L. R. (red.). (2017). AJCC Cancer Staging Manual (8. utg.). New York: Springer.

Amzallag-Bellenger, E., Soyer, P., Barbe, C., Diebold, M.-D., Cadiot, G., & Hoeffel, C. (2013). Prospective evaluation of magnetic resonance enterography for the detection of mesenteric small bowel tumours. European Radiology, 23(7), 1901-1910. https://doi.org/10.1007/s00330-013-2800-7

André, T., Meyerhardt, J., Iveson, T., Sobrero, A., Yoshino, T., Souglakos, I., . . . Shi, Q. (2020). Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. The Lancet. Oncology, 21(12), 1620-1629. https://doi.org/10.1016/s1470-2045(20)30527-1

Anzidei, M., Napoli, A., Zini, C., Kirchin, M. A., Catalano, C., & Passariello, R. (2011). Malignant tumours of the small intestine: a review of histopathology, multidetector CT and MRI aspects. The British journal of radiology, 84(1004), 677-690. https://doi.org/10.1259/bjr/20673379

Aparicio, T., Manfredi, S., Tougeron, D., Pam, A., Bouche, O., Pezet, D., . . . Afchain, P. (2015). A small bowel adenocarcinomas prospective cohort: Final analysis of demographic data from NADEGE study. United European Gastroenterology Journal, 1, A682. https://doi.org/10.1177/2050640615601623

Aparicio, T., Zaanan, A., Svrcek, M., Laurent-Puig, P., Carrere, N., Manfredi, S., . . . Afchain, P. (2014). Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Digestive and liver disease, 46(2), 97-104. https://doi.org/10.1016/j.dld.2013.04.013

Artigas, J. M., Martí, M., Soto, J. A., Esteban, H., Pinilla, I., & Guillén, E. (2013). Multidetector CT Angiography for Acute Gastrointestinal Bleeding: Technique and Findings. RadioGraphics, 33(5), 1453-1470. https://doi.org/10.1148/rg.335125072

Askling, J., Linet, M., Gridley, G., Halstensen, T. S., Ekström, K., & Ekbom, A. (2002). Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology, 123(5), 1428-1435. https://doi.org/10.1053/gast.2002.36585

Aydin, D., Sendur, M. A., Kefeli, U., Unal, O. U., Tastekin, D., Akyol, M., . . . Gumus, M. (2017a). Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection. Clinical colorectal cancer, 16(3), 220-227. https://doi.org/10.1016/j.clcc.2016.08.002

Aydin, D., Sendur, M. A., Kefeli, U., Ustaalioglu, B. B., Aydin, O., Yildirim, E., . . . Gumus, M. (2017b). Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma. Clinical colorectal cancer, 16(1), 78-83. https://doi.org/10.1016/j.clcc.2016.04.013

Bennett, C. M., Coleman, H. G., Veal, P. G., Cantwell, M. M., Lau, C. C., & Murray, L. J. (2015). Lifestyle factors and small intestine adenocarcinoma risk: A systematic review and meta-analysis. Cancer epidemiology, 39(3), 265-273. https://doi.org/10.1016/j.canep.2015.02.001

Benson, A. B., Venook, A. P., Al-Hawary, M. M., Arain, M. A., Chen, Y. J., Ciombor, K. K., . . . Gurski, L. A. (2019). Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 17(9), 1109-1133. https://doi.org/10.6004/jnccn.2019.0043

Bhamidipati, D., Colina, A., Hwang, H., Wang, H., Katz, M., Fournier, K., . . . Overman, M. J. (2021). Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy. ESMO Open, 6(3), 100132. https://doi.org/10.1016/j.esmoop.2021.100132

Bilimoria, K. Y., Bentrem, D. J., Wayne, J. D., Ko, C. Y., Bennett, C. L., & Talamonti, M. S. (2009). Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Annals of surgery, 249(1), 63-71. https://doi.org/10.1097/SLA.0b013e31818e4641

Bläker, H., von Herbay, A., Penzel, R., Gross, S., & Otto, H. F. (2002). Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Oncogene, 21(1), 158-164. https://doi.org/10.1038/sj.onc.1205041

Boffetta, P., Hazelton, W. D., Chen, Y., Sinha, R., Inoue, M., Gao, Y. T., . . . Potter, J. D. (2012). Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine--a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium. Annals of oncology, 23(7), 1894-1898. https://doi.org/10.1093/annonc/mdr562

Boyar Cetinkaya, R., Aagnes, B., Thiis-Evensen, E., Tretli, S., Bergestuen, D. S., & Hansen, S. (2017). Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010. Neuroendocrinology, 104(1), 1-10. https://doi.org/10.1159/000442207

Brierly, J. D., Gospodarowicz, M. K., & Wittekind, C. (red.). (2016). TNM: classification of malignant tumors (8 utg.). Oxford: Wiley-Blackwell.

Buragina, G., Magenta Biasina, A., & Carrafiello, G. (2019). Clinical and radiological features of mesenteric panniculitis: a critical overview. Acta Biomedica, 90(4), 411-422. https://doi.org/10.23750/abm.v90i4.7696

Bülow, S., Alm, T., Fausa, O., Hultcrantz, R., Järvinen, H., & Vasen, H. (1995). Duodenal adenomatosis in familial adenomatous polyposis. DAF Project Group. International journal of colorectal disease, 10(1), 43-46. https://doi.org/10.1007/bf00337586

Capurso, G., Rinzivillo, M., Bettini, R., Boninsegna, L., Delle Fave, G., & Falconi, M. (2012). Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. The British journal of surgery, 99(11), 1480-1486. https://doi.org/10.1002/bjs.8842

Casali, P. G., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bielack, S., . . . Blay, J. Y. (2018). Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 29(Suppl 4), iv68-iv78. https://doi.org/10.1093/annonc/mdy095

Chang, S. T., Desser, T. S., Gayer, G., & Menias, C. O. (2014). Metastatic melanoma in the chest and abdomen: the great radiologic imitator. Seminars in Ultrasound, CT and MRI, 35(3), 272-289. https://doi.org/10.1053/j.sult.2014.02.001

Coia, L., Hoffman, J., Scher, R., Weese, J., Solin, L., Weiner, L., . . . Hanks, G. (1994). Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. International journal of radiation oncology, biology, physics, 30(1), 161-167. https://doi.org/10.1016/0360-3016(94)90531-2

Crago, A. M., Chmielecki, J., Rosenberg, M., O'Connor, R., Byrne, C., Wilder, F. G., . . . Singer, S. (2015). Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. Genes, chromosomes & cancer, 54(10), 606-615. https://doi.org/10.1002/gcc.22272

Dabaja, B. S., Suki, D., Pro, B., Bonnen, M., & Ajani, J. (2004). Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer, 101(3), 518-526. https://doi.org/10.1002/cncr.20404

Daskalakis, K., Karakatsanis, A., Hessman, O., Stuart, H. C., Welin, S., Tiensuu Janson, E., . . . Stålberg, P. (2018). Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival. JAMA oncology, 4(2), 183-189. https://doi.org/10.1001/jamaoncol.2017.3326

Delaunoit, T., Neczyporenko, F., Limburg, P. J., & Erlichman, C. (2005). Pathogenesis and risk factors of small bowel adenocarcinoma: a colorectal cancer sibling? American Journal of Gastroenterology, 100(3), 703-710. https://doi.org/10.1111/j.1572-0241.2005.40605.x

Desmoid Tumor Working Group. (2020). The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. European journal of cancer, 127, 96-107. https://doi.org/10.1016/j.ejca.2019.11.013

Ecker, B. L., McMillan, M. T., Datta, J., Lee, M. K., Karakousis, G. C., Vollmer, C. M., Jr., . . . Roses, R. E. (2017). Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database. Cancer, 123(6), 967-976. https://doi.org/10.1002/cncr.30439

Ecker, B. L., McMillan, M. T., Datta, J., Mamtani, R., Giantonio, B. J., Dempsey, D. T., . . . Roses, R. E. (2016). Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis. Cancer, 122(5), 693-701. https://doi.org/10.1002/cncr.29840

Fiore, M., Coppola, S., Cannell, A. J., Colombo, C., Bertagnolli, M. M., George, S., . . . Raut, C. P. (2014). Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Annals of surgery, 259(5), 973-978. https://doi.org/10.1097/sla.0000000000000224

Fiore, M., Crago, A., Gladdy, R., & Kasper, B. (2021). The Landmark Series: Desmoid. Annals of Surgical Oncology, 28(3), 1682-1689. https://doi.org/10.1245/s10434-020-09395-5

Galiatsatos, P., & Foulkes, W. D. (2006). Familial adenomatous polyposis. American Journal of Gastroenterology, 101(2), 385-398. https://doi.org/10.1111/j.1572-0241.2006.00375.x

Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., . . . Offerhaus, J. A. (2000). Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology, 119(6), 1447-1453. https://doi.org/10.1053/gast.2000.20228

Gibson, M. K., Holcroft, C. A., Kvols, L. K., & Haller, D. (2005). Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist, 10(2), 132-137. https://doi.org/10.1634/theoncologist.10-2-132

Giuffrida, P., Arpa, G., Grillo, F., Klersy, C., Sampietro, G., Ardizzone, S., . . . Di Sabatino, A. (2020). PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability. Modern pathology, 33(7), 1398-1409. https://doi.org/10.1038/s41379-020-0497-0

Gronchi, A., Bonvalot, S., Poveda Velasco, A., Kotasek, D., Rutkowski, P., Hohenberger, P., . . . Casali, P. G. (2020). Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib. JAMA surgery, 155(6), e200397. https://doi.org/10.1001/jamasurg.2020.0397

Gulhati, P., Raghav, K., Shroff, R., Varadhachary, G., Javle, M., Qiao, W., . . . Overman, M. J. (2018). Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater. Oncologist, 23(3), 277-e226. https://doi.org/10.1634/theoncologist.2017-0568

Gulhati, P., Raghav, K., Shroff, R. T., Varadhachary, G. R., Kopetz, S., Javle, M., . . . Overman, M. J. (2017). Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study. Cancer, 123(6), 1011-1017. https://doi.org/10.1002/cncr.30445

Hallet, J., Law, C. H., Cukier, M., Saskin, R., Liu, N., & Singh, S. (2015). Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer, 121(4), 589-597. https://doi.org/10.1002/cncr.29099

Hashimoto, D., Arima, K., Chikamoto, A., Taki, K., Inoue, R., Kaida, T., . . . Baba, H. (2016). Limited Resection of the Duodenum for Nonampullary Duodenal Tumors, with Review of the Literature. American journal of surgery, 82(11), 1126-1132.

Helse- og omsorgsdepartementet. (2006a). Nasjonal helseplan (2007-2010) (Særtrykk av St.prp. nr. 1 (2006-2007) kapittel 6. ). Oslo: HOD. Hentet fra http://www.regjeringen.no/upload/HOD/Sykehus/Nasjonal_helseplan_Sartrykk.pdf

Helse- og omsorgsdepartementet. (2006b). Nasjonal strategi for kreftområdet 2006-2009. Oslo: HOD. Hentet fra https://www.regjeringen.no/no/dokumenter/nasjonal-strategi-for-kreftomradet/id446845/

Helse- og omsorgsdepartementet. (2013). Sammen - mot kreft. Nasjonal kreftstrategi 2013-2017. Oslo: HOD. Hentet fra https://www.iccp-portal.org/system/files/plans/kreftstrategien_2013.pdf

Helsedirektoratet. (2020). Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av nevroendokrine svulster i fordøyelsessystemet (2. utg.). (S-2946). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/nevroendokrine-svulster-i-fordoyelsessystemet-handlingsprogram

Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., . . . Aaltonen, L. A. (1998). A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature, 391(6663), 184-187. https://doi.org/10.1038/34432

Horimatsu, T., Nakayama, N., Moriwaki, T., Hirashima, Y., Fujita, M., Asayama, M., . . . Muto, M. (2017). A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma. International journal of clinical oncology, 22(5), 905-912. https://doi.org/10.1007/s10147-017-1138-6

Howdle, P. D., Jalal, P. K., Holmes, G. K., & Houlston, R. S. (2003). Primary small-bowel malignancy in the UK and its association with coeliac disease. Qjm, 96(5), 345-353. https://doi.org/10.1093/qjmed/hcg058

Huprich, J. E., Fletcher, J. G., Fidler, J. L., Alexander, J. A., Guimaraes, L. S., Siddiki, H. A., & McCollough, C. H. (2011). Prospective blinded comparison of wireless capsule endoscopy and multiphase CT enterography in obscure gastrointestinal bleeding. Radiology, 260(3), 744-751. https://doi.org/10.1148/radiol.11110143

Hølmebakk, T., Bjerkehagen, B., Lobmaier, I. V. K., Hompland, I., Stoldt, S., & Boye, K. (2019). Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors? Annals of Surgical Oncology, 26(13), 4730-4736. https://doi.org/10.1245/s10434-019-07813-x

Jagelman, D. G., DeCosse, J. J., & Bussey, H. J. (1988). Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet, 1(8595), 1149-1151. https://doi.org/10.1016/s0140-6736(88)91962-9

Jenne, D. E., Reimann, H., Nezu, J., Friedel, W., Loff, S., Jeschke, R., . . . Zimmer, M. (1998). Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nature genetics, 18(1), 38-43. https://doi.org/10.1038/ng0198-38

Joensuu, H. (2008). Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Human pathology, 39(10), 1411-1419. https://doi.org/10.1016/j.humpath.2008.06.025

Joensuu, H., Eriksson, M., Sundby Hall, K., Hartmann, J. T., Pink, D., Schütte, J., . . . Reichardt, P. (2012a). One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. Jama, 307(12), 1265-1272. https://doi.org/10.1001/jama.2012.347

Joensuu, H., Vehtari, A., Riihimäki, J., Nishida, T., Steigen, S. E., Brabec, P., . . . Rutkowski, P. (2012b). Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. The Lancet. Oncology, 13(3), 265-274. https://doi.org/10.1016/s1470-2045(11)70299-6

Kalkmann, J., Zeile, M., Antoch, G., Berger, F., Diederich, S., Dinter, D., . . . Stattaus, J. (2012). Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group. Cancer Imaging, 12(1), 126-135. https://doi.org/10.1102/1470-7330.2012.0013

Kelsey, C. R., Nelson, J. W., Willett, C. G., Chino, J. P., Clough, R. W., Bendell, J. C., . . . Czito, B. G. (2007). Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. International journal of radiation oncology, biology, physics, 69(5), 1436-1441. https://doi.org/10.1016/j.ijrobp.2007.05.006

Kim, K., Chie, E. K., Jang, J. Y., Kim, S. W., Oh, D. Y., Im, S. A., . . . Ha, S. W. (2012). Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience. American Journal of Clinical Oncology, 35(6), 533-536. https://doi.org/10.1097/COC.0b013e31821dee31

Kitahara, H., Honma, Y., Ueno, M., Kanemitsu, Y., Ohkawa, S., Mizusawa, J., . . . Shimada, Y. (2019). Randomized phase III trial of post-operative chemotherapy for patients with stage I/II/III small bowel adenocarcinoma (JCOG1502C, J-BALLAD). Japanese journal of clinical oncology, 49(3), 287-290. https://doi.org/10.1093/jjco/hyy188

Koornstra, J. J., Kleibeuker, J. H., & Vasen, H. F. (2008). Small-bowel cancer in Lynch syndrome: is it time for surveillance? The Lancet. Oncology, 9(9), 901-905. https://doi.org/10.1016/s1470-2045(08)70232-8

Kummar, S., Ciesielski, T. E., & Fogarasi, M. C. (2002). Management of small bowel adenocarcinoma. Oncology (Williston Park), 16(10), 1364-1369; discussion 1370, 1372-1363.

Legué, L. M., Simkens, G. A., Creemers, G. M., Lemmens, V., & de Hingh, I. (2017). Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon. European journal of cancer, 87, 84-91. https://doi.org/10.1016/j.ejca.2017.10.012

Legué, L. M., van Erning, F. N., Bernards, N., Lemmens, V., de Hingh, I., & Creemers, G. J. (2019). Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study. Targeted oncology, 14(6), 699-705. https://doi.org/10.1007/s11523-019-00681-1

Lepage, C., Bouvier, A. M., Manfredi, S., Dancourt, V., & Faivre, J. (2006). Incidence and management of primary malignant small bowel cancers: a well-defined French population study. American Journal of Gastroenterology, 101(12), 2826-2832. https://doi.org/10.1111/j.1572-0241.2006.00854.x

Lim, W., Hearle, N., Shah, B., Murday, V., Hodgson, S. V., Lucassen, A., . . . Houlston, R. S. (2003). Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. British journal of cancer, 89(2), 308-313. https://doi.org/10.1038/sj.bjc.6601030

Locher, C., Batumona, B., Afchain, P., Carrère, N., Samalin, E., Cellier, C., . . . Bouché, O. (2018). Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Digestive and liver disease, 50(1), 15-19. https://doi.org/10.1016/j.dld.2017.09.123

Lov om kommunale helse- og omsorgstjenester. (2011). LOV-2011-06-24-30. Hentet fra https://lovdata.no/dokument/NL/lov/2011-06-24-30

Martí, M., Artigas, J. M., Garzón, G., Alvarez-Sala, R., & Soto, J. A. (2012). Acute lower intestinal bleeding: feasibility and diagnostic performance of CT angiography. Radiology, 262(1), 109-116. https://doi.org/10.1148/radiol.11110326

Masselli, G., Di Tola, M., Casciani, E., Polettini, E., Laghi, F., Monti, R., . . . Gualdi, G. (2016). Diagnosis of Small-Bowel Diseases: Prospective Comparison of Multi-Detector Row CT Enterography with MR Enterography. Radiology, 279(2), 420-431. https://doi.org/10.1148/radiol.2015150263

McCarter, M. D., Antonescu, C. R., Ballman, K. V., Maki, R. G., Pisters, P. W., Demetri, G. D., . . . DeMatteo, R. P. (2012). Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence. Journal of the American College of Surgeons, 215(1), 53-59; discussion 59-60. https://doi.org/10.1016/j.jamcollsurg.2012.05.008

McWilliams, R. R., Foster, N. R., Mahoney, M. R., Smyrk, T. C., Murray, J. A., Ames, M. M., . . . Goetz, M. P. (2017). North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma. Cancer, 123(18), 3494-3501. https://doi.org/10.1002/cncr.30766

Minicozzi, P., Otter, R., Primic-Žakelj, M., Francisci, S., & red. (2015). Survival of Cancer Patients in Europe, 1999–2007: The EUROCARE-5 Study [temahefte]. European journal of cancer, 51(15).

National cancer institute. (2021). Cancer Stat Facts: Small Intestine Cancer. [nettdokument]. Bethesda, MD: National cancer institute. Hentet 11.11.2021, fra https://seer.cancer.gov/statfacts/html/smint.html

NCCN. (2020). Small Bowel Adenocarcinoma (Version 1.2020). (NCCN Clinical Practice Guidelines in Oncology (NCCN guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.

Neugut, A. I., Jacobson, J. S., Suh, S., Mukherjee, R., & Arber, N. (1998). The epidemiology of cancer of the small bowel. Cancer epidemiology, biomarkers & prevention, 7(3), 243-251.

Onkendi, E. O., Boostrom, S. Y., Sarr, M. G., Farnell, M. B., Nagorney, D. M., Donohue, J. H., . . . Que, F. G. (2012a). Neoadjuvant treatment of duodenal adenocarcinoma: a rescue strategy. Journal of gastrointestinal surgery, 16(2), 320-324. https://doi.org/10.1007/s11605-011-1667-7

Onkendi, E. O., Boostrom, S. Y., Sarr, M. G., Farnell, M. B., Nagorney, D. M., Donohue, J. H., . . . Que, F. G. (2012b). 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas. Journal of gastrointestinal surgery, 16(4), 682-691. https://doi.org/10.1007/s11605-011-1808-z

Overman, M. J., Adam, L., Raghav, K., Wang, J., Kee, B., Fogelman, D., . . . Kopetz, S. (2018). Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. Annals of oncology, 29(1), 139-144. https://doi.org/10.1093/annonc/mdx688

Overman, M. J., Hu, C. Y., Kopetz, S., Abbruzzese, J. L., Wolff, R. A., & Chang, G. J. (2012). A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease. Annals of Surgical Oncology, 19(5), 1439-1445. https://doi.org/10.1245/s10434-011-2173-6

Overman, M. J., Hu, C. Y., Wolff, R. A., & Chang, G. J. (2010a). Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database. Cancer, 116(23), 5374-5382. https://doi.org/10.1002/cncr.25324

Overman, M. J., Kopetz, S., Lin, E., Abbruzzese, J. L., & Wolff, R. A. (2010b). Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncology, 49(4), 474-479. https://doi.org/10.3109/02841860903490051

Overman, M. J., Varadhachary, G. R., Kopetz, S., Adinin, R., Lin, E., Morris, J. S., . . . Wolff, R. A. (2009). Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. Journal of Clinical Oncology, 27(16), 2598-2603. https://doi.org/10.1200/jco.2008.19.7145

Palascak-Juif, V., Bouvier, A. M., Cosnes, J., Flourié, B., Bouché, O., Cadiot, G., . . . Carbonnel, F. (2005). Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo. Inflammatory bowel diseases, 11(9), 828-832. https://doi.org/10.1097/01.mib.0000179211.03650.b6

Pedersen, K. S., Foster, N. R., Overman, M. J., Boland, P. M., Kim, S. S., Arrambide, K. A., . . . McWilliams, R. R. (2021). ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma. Clinical cancer research, 27(13), 3641-3648. https://doi.org/10.1158/1078-0432.Ccr-21-0159

Pennazio, M., Spada, C., Eliakim, R., Keuchel, M., May, A., Mulder, C. J., . . . Gralnek, I. M. (2015). Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy, 47(4), 352-376. https://doi.org/10.1055/s-0034-1391855

Ricci, R. (2016). Syndromic gastrointestinal stromal tumors. Hereditary cancer in clinical practice, 14, 15. https://doi.org/10.1186/s13053-016-0055-4

Rompteaux, P., Gagnière, J., Gornet, J. M., Coriat, R., Baumgaertner, I., Lecomte, T., . . . Aparicio, T. (2019). Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study. European journal of surgical oncology, 45(3), 331-335. https://doi.org/10.1016/j.ejso.2018.11.012

Rovers, K. P., de Bree, E., Yonemura, Y., & de Hingh, I. H. (2017). Treatment of peritoneal metastases from small bowel adenocarcinoma. International journal of hyperthermia, 33(5), 571-578. https://doi.org/10.1080/02656736.2016.1266700

Rutkowski, P., Gronchi, A., Hohenberger, P., Bonvalot, S., Schöffski, P., Bauer, S., . . . van Coevorden, F. (2013). Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Annals of Surgical Oncology, 20(9), 2937-2943. https://doi.org/10.1245/s10434-013-3013-7

Sadigh, G., Applegate, K. E., & Baumgarten, D. A. (2014). Comparative accuracy of intravenous contrast-enhanced CT versus noncontrast CT plus intravenous contrast-enhanced CT in the detection and characterization of patients with hypervascular liver metastases: a critically appraised topic. Academic radiology, 21(1), 113-125. https://doi.org/10.1016/j.acra.2013.08.023

Sandvik, O. M., Søreide, K., Gudlaugsson, E., Kvaløy, J. T., & Søreide, J. A. (2016). Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria. The British journal of surgery, 103(3), 226-232. https://doi.org/10.1002/bjs.10034

Sandvik, O. M., Søreide, K., Kvaløy, J. T., Gudlaugsson, E., & Søreide, J. A. (2011). Epidemiology of gastrointestinal stromal tumours: single-institution experience and clinical presentation over three decades. Cancer epidemiology, 35(6), 515-520. https://doi.org/10.1016/j.canep.2011.03.002

Schottenfeld, D., Beebe-Dimmer, J. L., & Vigneau, F. D. (2009). The epidemiology and pathogenesis of neoplasia in the small intestine. Annals of epidemiology, 19(1), 58-69. https://doi.org/10.1016/j.annepidem.2008.10.004

Schrock, A. B., Devoe, C. E., McWilliams, R., Sun, J., Aparicio, T., Stephens, P. J., . . . Overman, M. J. (2017). Genomic Profiling of Small-Bowel Adenocarcinoma. JAMA oncology, 3(11), 1546-1553. https://doi.org/10.1001/jamaoncol.2017.1051

Shenoy, S. (2016). Genetic risks and familial associations of small bowel carcinoma. World journal of gastrointestinal oncology, 8(6), 509-519. https://doi.org/10.4251/wjgo.v8.i6.509

Shi, C., Berlin, J., Branton, P. A., Fitzgibbons, P.-L.-., Frankel, W. L., Hofstetter, W. L., . . . Washington, M. K. (2017). Protocol for the Examination of Specimens From Patients With Carcinoma of the Small Intestine. Northfield, IL: College of Americal Pathologists. Hentet fra https://documents.cap.org/protocols/cp-small-intestine-17protocol-4000.pdf

Soyer, P., Aout, M., Hoeffel, C., Vicaut, E., Placé, V., & Boudiaf, M. (2013). Helical CT-enteroclysis in the detection of small-bowel tumours: a meta-analysis. European Radiology, 23(2), 388-399. https://doi.org/10.1007/s00330-012-2595-y

Swartz, M. J., Hughes, M. A., Frassica, D. A., Herman, J., Yeo, C. J., Riall, T. S., . . . Abrams, R. A. (2007). Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Archives of surgery, 142(3), 285-288. https://doi.org/10.1001/archsurg.142.3.285

Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., . . . Jaffe, E. S. (2016). The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood, 127(20), 2375-2390. https://doi.org/10.1182/blood-2016-01-643569

Takayoshi, K., Kusaba, H., Uenomachi, M., Mitsugi, K., Makiyama, C., Makiyama, A., . . . Baba, E. (2017). Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer. Cancer chemotherapy and pharmacology, 80(2), 333-342. https://doi.org/10.1007/s00280-017-3371-0

Talamonti, M. S., Goetz, L. H., Rao, S., & Joehl, R. J. (2002). Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Archives of surgery, 137(5), 564-570; discussion 570-561. https://doi.org/10.1001/archsurg.137.5.564

Tran, T. B., Qadan, M., Dua, M. M., Norton, J. A., Poultsides, G. A., & Visser, B. C. (2015). Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma. Surgery, 158(2), 486-493. https://doi.org/10.1016/j.surg.2015.03.048

Tsushima, T., Taguri, M., Honma, Y., Takahashi, H., Ueda, S., Nishina, T., . . . Boku, N. (2012). Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy. Oncologist, 17(9), 1163-1170. https://doi.org/10.1634/theoncologist.2012-0079

Vasen, H. F., Wijnen, J. T., Menko, F. H., Kleibeuker, J. H., Taal, B. G., Griffioen, G., . . . Khan, P. M. (1996). Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 110(4), 1020-1027. https://doi.org/10.1053/gast.1996.v110.pm8612988

Warth, A., Kloor, M., Schirmacher, P., & Bläker, H. (2011). Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMP. Modern pathology, 24(4), 564-570. https://doi.org/10.1038/modpathol.2010.223

Weber, N. K., Fletcher, J. G., Fidler, J. L., Barlow, J. M., Pruthi, S., Loftus, E. V., . . . Bruining, D. H. (2015). Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohn’s disease. Abdominal Imaging, 40(5), 1060-1067. https://doi.org/10.1007/s00261-014-0144-7

WHO Classification of Tumours Editorial Board (red.). (2019). Digestive System Tumours (5. utg.). (WHO Classification of Tumours, Volume 1). Lyon: IARC.

WHO Classification of Tumours Editorial Board (red.). (2020). Soft Tissue and Bone Tumours (5. utg.). (WHO Classification of Tumours, Volume 3). Lyon: IARC.

Wilhelm, A., Müller, S. A., Steffen, T., Schmied, B. M., Beutner, U., & Warschkow, R. (2016). Patients with Adenocarcinoma of the Small Intestine with 9 or More Regional Lymph Nodes Retrieved Have a Higher Rate of Positive Lymph Nodes and Improved Survival. Journal of gastrointestinal surgery, 20(2), 401-410. https://doi.org/10.1007/s11605-015-2994-x

Xiang, X. J., Liu, Y. W., Zhang, L., Qiu, F., Yu, F., Zhan, Z. Y., . . . Xiong, J. P. (2012). A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma. Anticancer Drugs, 23(5), 561-566. https://doi.org/10.1097/CAD.0b013e328350dd0d

Yang, C. B., Yu, N., Jian, Y. J., Yu, Y., Duan, H. F., Zhang, X. R., . . . Duan, X. (2019). Spectral CT Imaging in the Differential Diagnosis of Small Bowel Adenocarcinoma From Primary Small Intestinal Lymphoma. Academic radiology, 26(7), 878-884. https://doi.org/10.1016/j.acra.2018.08.020

Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., . . . Evans, D. B. (2008). One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of Clinical Oncology, 26(18), 3063-3072. https://doi.org/10.1200/jco.2007.15.4377

Ye, X., Zhang, G., Chen, H., & Li, Y. (2018). Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma. PLoS One, 13(8), e0200204. https://doi.org/10.1371/journal.pone.0200204

Yeung, R. S., Weese, J. L., Hoffman, J. P., Solin, L. J., Paul, A. R., Engstrom, P. F., . . . Eisenberg, B. L. (1993). Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study. Cancer, 72(7), 2124-2133. https://pubmed.ncbi.nlm.nih.gov/8374871/

Zhang, L., Wang, L. Y., Deng, Y. M., Wang, F. H., Feng, F., Chen, Y. C., . . . Li, Y. H. (2011). Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: a three-center study from China. Journal of B.U.ON., 16(4), 689-696.

Zhang, S., Yuan, W., Zhang, J., Chen, Y., Zheng, C., Ma, J., . . . Wang, C. (2017). Clinicopathological features, surgical treatments, and survival outcomes of patients with small bowel adenocarcinoma. Medicine (Baltimore), 96(31), e7713. https://doi.org/10.1097/md.0000000000007713

Zaanan, A., Costes, L., Gauthier, M., Malka, D., Locher, C., Mitry, E., . . . Aparicio, T. (2010). Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study. Annals of oncology, 21(9), 1786-1793. https://doi.org/10.1093/annonc/mdq038

Zaanan, A., Gauthier, M., Malka, D., Locher, C., Gornet, J. M., Thirot-Bidault, A., . . . Aparicio, T. (2011). Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study. Cancer, 117(7), 1422-1428. https://doi.org/10.1002/cncr.25614

Sist faglig oppdatert: 03. februar 2023